drugset / Trial / NCT02751125

Reconstruction of Jaw Bone Using Mesenchymal Stem Cells

NCT02751125

NaSingle-groupOpen-labelTreatment

Summary

This pilot study is aimed to reconstruct atrophied posterior alveolar mandibular ridges using biomaterial and autologous bone marrow derived stem cells (BMMSC) and to insert an implant into the new bone in a prosthetically guided position.

Timeline

Start
2014-06
Primary completion
2019-03-01
Completion
2020-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject mesenchymal stem cells Cell therapy